Navigation Links
uKarma to Open First Xflowsion Fitness Studio With Celebrity Trainer Eric Paskel
Date:7/9/2008

Xflowsion studio is part of uKarma's vertical integration strategy and will serve as a platform to launch complementary health and wellness brands

LOS ANGELES, July 9 /PRNewswire-FirstCall/ -- uKarma Corporation (OTC Bulletin Board: UKMA), a lifestyle multimedia and consumer products company focused on health, wellness and personal development, announced today the first Xflowsion studio will open in Southern California in October, 2008.

Xflowsion, with its revolutionary Triple Training(R), is the only exercise program that efficiently and effectively combines the best elements of three proven workouts: martial arts, power yoga, and dance, into one convenient and fun workout, producing jaw-dropping results in one-third the time.

uKarma Corporation executed a lease for a 6,200 square foot studio location in the Los Angeles area on Ventura Blvd in Sherman Oaks California. The studio will showcase Xflowsion classes led by celebrity trainer Eric Paskel, as well as yoga and fitness classes. The Xflowsion studio will feature live bands, DJ's, organic food & beverages as well as retail products including DVDs, clothing, and fitness and yoga accessories.

The Xflowsion studio is part of uKarma's vertical integration strategy for its Xflowsion brand. uKarma expects demand created by it's DVD sales will be channeled into other revenue steams such as studios offering live classes, as well as teacher training and retreats. The Xflowsion studio will also serve as a platform to launch complimentary health and wellness brands such as yoga mats, fitness apparatuses, packaged snack foods, beverages and clothing.

"We are thrilled to announce the opening of our first Xflowsion studio," said Bill Glaser, CEO of uKarma Corp. "Following the successful launch of the Xflowsion DVD series and infomercial, opening a dedicated Xflowsion studio was the natural next step in continuing to build our brand. We expect to open Xflowsion studios around the count
'/>"/>

SOURCE uKarma Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. uKarma Corporation Commences International Distribution Agreement With Northern Response for its Xflowsion DVD Series
2. First biomarker discovered that predicts prostate cancer outcome
3. FDA Approves First Anti-Psychotic for Kids
4. Single-incision belly-button surgery to remove kidney performed first at UT Southwestern
5. First study examines newly-licensed RN work attitudes and intentions
6. Glades General Hospital First in Palm Beach County to Provide On-Site Electronic Birth Registration
7. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
8. Father and Daughter From Tanzania Receive Their First Medical Examination in Newport Beach
9. High and mighty: first common height gene identified by researchers behind obesity gene finding
10. APA Comments on FDAs First Approval of Medication to Treat Pediatric Schizophrenia and Bipolar Disorder
11. TriWest Creates First-of-its-Kind Partnership to Offer Military Leaders With Grief Support Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/8/2008)...aser scalpels, arthroscopic,surgery, genomic resea...rinary medicine is quickly expanding into new high...e benefit; it,s improving medicine for,people, too... care for their pets to,treat diseases like diabet... according to the American Veterinary Medical Asso...
(Date:9/8/2008)...zine examines Iraq and Afghanistan veterans, strug..., Washington, DC (PRWEB) S...by veterans of the Iraq and Afghanistan wars about... addiction disorders are featured in the current i...ublication of the National Council for Community B...
(Date:9/7/2008)...f older patients successfully treated for colorect...le to detect any recurrence of cancer. The study, ... , a peer-reviewed journal of the American Cancer ...monitoring of colorectal cancer survivors could af...y curative surgery for colorectal cancer have an i...
(Date:9/7/2008)... appear to lower a man,s PSA level, the blood biom...her a man is at risk of prostate cancer. , But t.... 8 in the journal Cancer , caution that men shou... prostate cancer just yet. , "We showed that me...rin and other non-steroidal anti-inflammatory drug...
Breaking Medicine News(10 mins):Health News:High-Tech Vet Medicine Saving Lives of Pets and People 2Health News:Helping Veterans in Our Communities 2Health News:Helping Veterans in Our Communities 3Health News:Many colorectal cancer survivors do not receive recommended follow-up care 2Health News:Common painkillers lower levels of prostate cancer biomarker 2
...Health occupies an important position on the Natio...t’s announcement last month. The obvious reason, c...omers for sexually transmitted diseases. // Durin...n the exact position of facilities available, alm...
...rginia Health System reserachers have identified a... drugs used in the treatment of acute respiratory ...n in onset and is a life-threatening condition. ... the sense of sight, smell and taste (G-protein co...
...ter Anbumani Ramadoss urged the Prime Minister Mr....enting the ban on smoking in the films and televis...ion and broadcasting failing to reach consensus on...roposed by Ramadoss, the minister approached Prime...
...ecent study researchers might be able to isolates ... learning and memory.// The revolutionary study ha...dical School and Children's Hospital Boston and th...rotein that shows how neurons change as a result o...
Other Medicine News:
(Date:9/4/2008)... for Obstetrician-Gynecologists States UFE Meets L...ally Invasive Interventional,Radiology Treatment I...broids, FAIRFAX, Va., Sept. 4 /PRNewswire-USNewsw... national organization of nearly 4,500 doctors,sc... to improving health,care through minimally invasi...
(Date:9/4/2008)...urvival Data for Ipilimumab to be Presented, PRIN...arex, Inc.,(Nasdaq: MEDX ) announced today that n...ational anti-CTLA-4 antibody, in melanoma are sche...rd Congress of the European Society,for Medical On...Stockholm.,Many of the following abstracts will in...
(Date:9/3/2008)..., Sept. 4 /Xinhua--,Pharmac... today announced,that it has enrolled the first su...al evaluating Bronchitol in cystic fibrosis suffer...hospitals across North,America, Argentina and Germ...is seeks approval to market Bronchitol for cystic ...
(Date:9/3/2008)...w up results from chronically infected Hepatitis C...a obtained earlier in 2008, - Study is the first... antiviral effect of therapeutic Hepatitis ...support move into a second generation, vaccine fo...through TLR activati...
Breaking Medicine Technology:Society of Interventional Radiology Applauds Report's Uterine Fibroid Embolization Recommendations 2Society of Interventional Radiology Applauds Report's Uterine Fibroid Embolization Recommendations 3Medarex Announces Presentations at the 33rd Congress of the European Society for Medical Oncology 2Medarex Announces Presentations at the 33rd Congress of the European Society for Medical Oncology 3Second Pivotal Phase 3 Trial In Cystic Fibrosis Begins 2Second Pivotal Phase 3 Trial In Cystic Fibrosis Begins 3Favourable Six Months Follow-Up Results From Intercell's Phase II Therapeutic Hepatitis C Program 2Favourable Six Months Follow-Up Results From Intercell's Phase II Therapeutic Hepatitis C Program 3Favourable Six Months Follow-Up Results From Intercell's Phase II Therapeutic Hepatitis C Program 4Famed Attorney Willie Gary Files 2410 6 Billion in Lawsuits against Big Tobacco Companies on Behalf of Florida Smokers and their Families 9398 1Famed Attorney Willie Gary Files 2410 6 Billion in Lawsuits against Big Tobacco Companies on Behalf of Florida Smokers and their Families 9398 2Abington Memorial Hospital Completes System Wide Conversion to Masimo SET Pulse Oximetry Technology 2551 1Abington Memorial Hospital Completes System Wide Conversion to Masimo SET Pulse Oximetry Technology 2551 2Abington Memorial Hospital Completes System Wide Conversion to Masimo SET Pulse Oximetry Technology 2551 3Abington Memorial Hospital Completes System Wide Conversion to Masimo SET Pulse Oximetry Technology 2551 4Climate change gender differences health among EurekAlert 21 10 Most Popular Stories in 2007 9393 1Climate change gender differences health among EurekAlert 21 10 Most Popular Stories in 2007 9393 2Climate change gender differences health among EurekAlert 21 10 Most Popular Stories in 2007 9393 3Climate change gender differences health among EurekAlert 21 10 Most Popular Stories in 2007 9393 4Climate change gender differences health among EurekAlert 21 10 Most Popular Stories in 2007 9393 5Climate change gender differences health among EurekAlert 21 10 Most Popular Stories in 2007 9393 6Extreme obesity affects chances of kidney transplantation 9391 1Extreme obesity affects chances of kidney transplantation 9391 2
...e-FirstCall/ -- CEL-SCI,CORPORATION announces that...nst hepatitis B antigen, and that the combination ... adjuvant delivery,system owned by Mercia Pharma, ...nti-HBV (hepatitis B virus) antibodies. These find...r Vice President of,Research, Cellular Immunology ...
...- Genentech, Inc. (NYSE:DNA),and Biogen Idec, Inc.... Phase II clinical study of Rituxan(R) (rituximab)...erosis (RRMS) were,presented today at the American...n. Rituxan is a therapeutic antibody that targets ...There remains a great need for safe and effective ...
Other Medicine Technology:CEL-SCI's Cel-1000 Shown to Significantly Enhance Immune Response,Against Hepatitis B Antigen in Animals 2Rituxan Phase II Data in Patients with Relapsing-Remitting Multiple,Sclerosis Presented at the American Academy of Neurology 2Rituxan Phase II Data in Patients with Relapsing-Remitting Multiple,Sclerosis Presented at the American Academy of Neurology 3Rituxan Phase II Data in Patients with Relapsing-Remitting Multiple,Sclerosis Presented at the American Academy of Neurology 4Rituxan Phase II Data in Patients with Relapsing-Remitting Multiple,Sclerosis Presented at the American Academy of Neurology 5Rituxan Phase II Data in Patients with Relapsing-Remitting Multiple,Sclerosis Presented at the American Academy of Neurology 6
WorldHeart's Novacor LVAS is an implanted, wearable system that provides pulsatile circulatory support for patients with life-threatening heart failure. ,Novacor LVAS has been implanted in more
...s first minimally-invasive epicardial lead placeme... Implant Tool, which has been cleared for marketin...ailable to implanting physicians who place the Med...er implants. The tool furthers the trend moving aw...
It is a cardio-pulmonary exercise testing device.
...patient safety, dependability and overall performa...vides an extra margin of safety for patients. The...tandstill to accommodate severely debilitated pati...ilitates accurate blood pressure measurements even...
Medicine Products: